PUVA and interferon α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven-year retrospective study in Russia

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e72-e74. doi: 10.1111/jdv.15212. Epub 2018 Sep 5.

Authors

O Y Olisova¹, M Megna², E V Grekova¹, D V Zaslavsky³, L G Gorenkova⁴, A A Sidikov³, E A Timoshchuk³

Affiliations

¹ Department of Skin and Sexually Transmitted Diseases, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
² Section of Dermatology, Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Saint Petersburg, Russia.
³ Department of Dermatovenereology, Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia.
⁴ National Medical Hematology Research Center, Moscow, Russia.

PMID: 30102807
DOI: 10.1111/jdv.15212

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Female
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Male
Middle Aged
Mycosis Fungoides / drug therapy*
PUVA Therapy*
Retrospective Studies
Russia

Substances

Interferon alpha-2
Interferon-alpha
Interferon-alpha2b